CVA Family Office, LLC
Family OfficePosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1802084
DENVER, CO
Position in VRTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$239,423
+$28,657 QoQ
Shares Held
482
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,343
of 1,745 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CVA Family Office, LLC holds $743,661 across 48 Biotechnology names. VRTX ranks #1 (32.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
482 | $239,423 | |
| 2 | MRNA |
Moderna, Inc.
|
1,693 | $118,560 | |
| 3 | INCY |
Incyte Corp
|
892 | $101,117 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
143 | $89,166 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
96 | $28,898 | |
| 6 | EXEL |
Exelixis, Inc.
|
364 | $19,805 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
81 | $19,518 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
472 | $16,704 |
All Filings in VRTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $239,423 | 482 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $210,766 | 472 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $178,170 | 393 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $151,956 | 388 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $170,066 | 382 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $207,018 | 427 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $154,234 | 383 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $161,847 | 348 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $158,896 | 339 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $136,271 | 326 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $132,239 | 325 | Shares | Sole | 2024-01-16 | |
| 2023-06-30 | $105,573 | 300 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $92,945 | 295 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $114,068 | 395 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $79,623 | 275 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $66,220 | 235 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $61,327 | 235 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $21,960 | 100 | Shares | Sole | 2022-01-25 | |
| 2021-06-30 | $18,348 | 91 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $33,307 | 155 | Shares | Sole | 2021-04-14 | |
| No filing history on record for this holder in this stock. | ||||||